Keveyis (Strongbridge US Inc.)


Welcome to the PulseAid listing for the Keveyis drug offered from Strongbridge US Inc.. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Strongbridge US Inc.
NON-PROPRIETARY NAME: Dichlorphenamide
SUBSTANCE NAME: DICHLORPHENAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-08-07
END MARKETING DATE: 0000-00-00


Keveyis HUMAN PRESCRIPTION DRUG Details:

Item DescriptionKeveyis from Strongbridge US Inc.
LABELER NAME: Strongbridge US Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2015-08-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 71090-001_8f5b2baf-b828-4731-a9d3-88a800649e38
PRODUCT NDC: 71090-001
APPLICATION NUMBER: NDA011366

Other DICHLORPHENAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Strongbridge US Inc.Keveyis
Taro Pharmaceuticals U.S.A., inc.Keveyis
Taro Pharmaceuticals U.S.A., Inc.DARANIDE